As expected, the high proliferation rates of Nrf2 OE and Keap1 KD could be confirmed by these experiments and Nrf2 OE and Keap1 KD gliomas showed almost four to five times higher cell growth in comparison to controls (Figure 3b). The gene discussed is KEAP1; the disease is glioma.